Evidence map›Paper›PMID 29559644›Full record

ArticleScientific reports2018

Bone-related Circulating MicroRNAs miR-29b-3p, miR-550a-3p, and miR-324-3p and their Association to Bone Microstructure and Histomorphometry.

Xaver Feichtinger, Christian Muschitz, Patrick Heimel, Andreas Baierl, Astrid Fahrleitner-Pammer, Heinz Redl, Heinrich Resch, Elisabeth Geiger, Susanna Skalicky, Rainer Dormann and 5 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it, 83 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. MicroRNA and Diabetic Bone Disease.Current osteoporosis reports · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. A systematic review of miRNAs as biomarkers in osteoporosis disease.Journal of diabetes and metabolic disorders · 2021
    Article
  18. Article
  19. Article
  20. Circulating MiR-21 expression is upregulated after 30 days of head-down tilt bed rest.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 3 countries.

Xaver FeichtingerLudwig Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, Austria.
Christian MuschitzSt. Vincent Hospital - Medical Department II, The VINFORCE Study Group, Academic Teaching Hospital of the Medical University of Vienna, Vienna, Austria.
Patrick HeimelLudwig Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, Austria.
Andreas BaierlDepartment of Statistics and Operations Research, University of Vienna, Vienna, Austria.
Astrid Fahrleitner-PammerDepartment of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
Heinz RedlLudwig Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, Austria.ORCID 0000-0003-1654-462X
Heinrich ReschSt. Vincent Hospital - Medical Department II, The VINFORCE Study Group, Academic Teaching Hospital of the Medical University of Vienna, Vienna, Austria.
Elisabeth GeigerTAmiRNA GmbH, Vienna, Austria.
Susanna SkalickyTAmiRNA GmbH, Vienna, Austria.
Rainer DormannSt. Vincent Hospital - Medical Department II, The VINFORCE Study Group, Academic Teaching Hospital of the Medical University of Vienna, Vienna, Austria.
Fabian PlachelSt. Vincent Hospital - Medical Department II, The VINFORCE Study Group, Academic Teaching Hospital of the Medical University of Vienna, Vienna, Austria.
Peter PietschmannDepartment of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Johannes GrillariTAmiRNA GmbH, Vienna, Austria.
Matthias HacklTAmiRNA GmbH, Vienna, Austria. matthias.hackl@tamirna.com.
Roland KocijanLudwig Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, Austria.
St Vincent Hospital · USLudwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA · ATBOKU University · ATMedical University of Graz · ATMedical University of Vienna · ATSigmund Freud Privatuniversität Wien · ATUniversity of Kashmir · INUniversity of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The assessment of bone quality and the prediction of fracture risk in idiopathic osteoporosis (IOP) are complex prospects as bone mineral density (BMD) and bone turnover markers (BTM) do not indicate fracture-risk. MicroRNAs (miRNAs) are promising new biomarkers for bone diseases, but the current understanding of the biological information contained in the variability of miRNAs is limited. Here, we investigated the association between serum-levels of 19 miRNA biomarkers of idiopathic osteoporosis to bone microstructure and bone histomorphometry based upon bone biopsies and µCT (9.3 μm) scans from 36 patients. Four miRNAs were found to be correlated to bone microarchitecture and seven miRNAs to dynamic histomorphometry (p < 0.05). Three miRNAs, namely, miR-29b-3p, miR-324-3p, and miR-550a-3p showed significant correlations to histomorphometric parameters of bone formation as well as microstructure parameters. miR-29b-3p and miR-324-p were found to be reduced in patients undergoing anti-resorptive therapy. This is the first study to report that serum levels of bone-related miRNAs might be surrogates of dynamic histomorphometry and potentially reveal changes in bone microstructure. Although these findings enhance the potential value of circulating miRNAs as bone biomarkers, further experimental studies are required to qualify the clinical utility of miRNAs to reflect dynamic changes in bone formation and microstructure.

Indexed as

AdultBiomarkersBone and BonesBone DensityCirculating MicroRNACross-Sectional StudiesFemaleGene Expression ProfilingHumansMaleMicroRNAsMiddle AgedOsteogenesisOsteoporosisOsteoporosis, PostmenopausalOsteoporotic FracturesBiomarkersCirculating MicroRNAMicroRNAsMIRN29a microRNA, humanMIRN324 microRNA, humanMIRN550 microRNA, human

Identifiers

PMID29559644
PMCPMC5861059
OpenAlexW2797162554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.